Improving Care: More Method, Less Uncertainty, Impact summit
30 October 2013
Improving Care: More Method, Less Uncertainty – Impact Summit, the second full day event in the Measurement Masterclass series, took place at the Central Hall Westminster in London on 30 October. The event was opened by Professor Sir Bruce Keogh and NHS IQ’s own Professor Moira Livingston, and included contributions from experts from across England and a virtual appearance by Dr Bob Lloyd.
This series for senior clinical leaders was developed to help increase the understanding of the principles of measurement for improvement. Designed to stimulate and challenge, it is supporting clinical leads in holding influential discussions with policy makers and data collectors.
To take the series forward and promote measurement for improvement more widely, NHS Improving Quality is setting up an advisory group to design and develop more learning resources for senior clinicians and their teams
More information: http://www.nhsiq.nhs.uk/capacity-capability/measurement-masterclass.aspx
A study on effect of cme programs in improving doctors medical practice__BHAV...Bhavik Amin
Download this ppt . It is prepared after doing survey of 36 doctors in Ahmedabad circle.It contains useful information on Type ,facilities and current scenerio of CME program and effect of CME program on doctors medical practice.
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
An integrated model of psychosocial cancer care: a work in progress…Cancer Institute NSW
Cancer patients are faced with a multitude of stressors, from diagnosis, through treatment, at recurrence, in the stages following treatment completion, and in the terminal phase. Psychosocial care has been highlighted as a critical aspect of providing comprehensive patient-focused care. Specifically, one of the goals of The NSW Cancer Plan 2011-2015 is to improve the quality of life of people with cancer and their carers. This project was initiated to improve the current psychosocial model of care at The Kinghorn Cancer Centre (TKCC), to better reflect an integrated, holistic and comprehensive model of patient-centred care.
A study on effect of cme programs in improving doctors medical practice__BHAV...Bhavik Amin
Download this ppt . It is prepared after doing survey of 36 doctors in Ahmedabad circle.It contains useful information on Type ,facilities and current scenerio of CME program and effect of CME program on doctors medical practice.
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
An integrated model of psychosocial cancer care: a work in progress…Cancer Institute NSW
Cancer patients are faced with a multitude of stressors, from diagnosis, through treatment, at recurrence, in the stages following treatment completion, and in the terminal phase. Psychosocial care has been highlighted as a critical aspect of providing comprehensive patient-focused care. Specifically, one of the goals of The NSW Cancer Plan 2011-2015 is to improve the quality of life of people with cancer and their carers. This project was initiated to improve the current psychosocial model of care at The Kinghorn Cancer Centre (TKCC), to better reflect an integrated, holistic and comprehensive model of patient-centred care.
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Naz Usmani
A very brief presentation about the clinical process improvements including practices, standards of care , guideline and pathway . I have reflected upon the basic differences between them . Hope it is useful
ISCaHN Treatment Dashboard: Providing clinician decision support with data ge...Cancer Institute NSW
Illawarra Shoalhaven Cancer and Haematology Network (ISCaHN) has been using an oncology information system (OIS) as a complete electronic record for over 4 years. There has been both considerable and valuable treatment data generated at the point of care. Are we able to rapidly assess the outcomes of our own treatment data, and use this outcome data to help inform the delivery of care to our patients?
Methods for Observational Comparative Effectiveness Research on Healthcare De...Marion Sills
Research Objective: The SAFTINet project was funded by the AHRQ to build a distributed network of existing clinical and claims data that would support comparative effectiveness research (CER), with a focus on underserved populations and healthcare delivery system (HDS) characteristics. Observational research methods are appropriate, but require detailed protocols with a priori hypotheses and analytic plans. SAFTINet research specifically concerns the effects of a discrete set of HDS features (those often included in Patient-Centered Medical Home (PCMH) models) on health outcomes for primary care patients with asthma, hypertension, and hypercholesterolemia. Our objective is to present a description of this study’s measurement challenges, and to specify a priori hypotheses, analytic strategies, and plans for addressing bias and confounding for our asthma cohorts.
Study Design: An observational, longitudinal cohort study of primary care patients with asthma, with both secondary use of existing clinical and claims data and primary data collection for HDS features and patient- reported outcomes.
Population Studied: Our sample consists of 59 primary care practices in 5 healthcare organizations in Colorado, Utah and Tennessee; all practices serve underserved populations. These practices care for about 275,000 patients per year, of whom an estimated 22,000 have a diagnosis of asthma.
Principal Findings: We will present the processes used to define and measure the HDS features, covariates and asthma outcomes, along with planned analysis. Challenges include valid measurement of a multi-faceted HDS “exposure” variable, the inability to identify exposure onset, and the non-dichotomous nature of HDS characteristics. To measure HDS characteristics, we created a practice-level survey assessing 9 PCMH domains, including care coordination, specialty care and mental health integration, and patient-centeredness, as well as asthma-specific HDS characteristics (e.g., the use of asthma registries). Asthma outcomes included (1) those available as a result of routine electronic documentation of clinical care and claims administration (utilization indicative of an exacerbation), and (2) patient reported outcomes tools (Asthma Control Test). We used directed acyclic graphs to identify potential confounders of the relationship between HDS characteristics and asthma control, as well as other potential biases. The analytic plan is based on linear mixed effects models. Perspectives of the CER team, the technology team and the community engagement group were considered in the operationalization of all variables.
Conclusions: The design of rigorous observational CER observational CER should recognize the need for an intense planning phase. In accordance with good practice guidance for observational studies, an important component of the planning phase is to disseminate and obtain feedback on the research design in advance of its conduct.
Building the bridge from discovery-to-delivery: A Community of Practice in Ca...Cancer Institute NSW
A research breakthrough is said to take approximately 17 years to translate into clinical practice. This time lag can have considerable implications for patients, their carers, health services, and public funds. To address this time lag, the Cancer Institute NSW and the Translational Cancer Research Centres (TCRCs) across the state developed a community of practice (CoP) to increase knowledge, skills, and capacity in implementation science.
Pathways to smoking care for cancer patients (P-SCIP): Stage 1Cancer Institute NSW
As survival from cancer has improved over time, the potential impact of cigarette smoking on cancer patients and survivors is of increasing relevance. In addition to increased risk of chronic disease such as cardiovascular and respiratory disease, continued smoking after a cancer diagnosis increases the risk of second primary cancer, cancer recurrence and is a cause of treatment complications. As well the profound adverse impact of continued smoking on health outcomes in cancer patients, continued smoking among people with cancer incurs significant cost to the health system.
Member experiences in an Australian Translational Cancer Research Centre and ...Cancer Institute NSW
The experience of membership of multidisciplinary collaborative cancer research networks is largely unreported. Sydney Catalyst Translational Cancer Research Centre (TCRC) is a multi-disciplinary and multi-institutional virtual consortium of researchers and clinicians from institutions in metropolitan Sydney and regional New South Wales. Following the Westfall model of translational research, we support multi-disciplinary collaborative cancer research focused on T1112 bench to bedside research and T2/3 translation of evidence into practice.
Paul Bristow, BKPA, and Karen Thomas, UKRR gave a presentation at BRS2017: Embedding patient reported experience into future QI - 1st National PREM Pilot Survey 2016
Specialist and Associate Specialist (SAS) doctors are highly experienced and highly skilled doctors working in the UK NHS. Now SAS doctors can register with their employer to be recognised as 'Autonomous Practitioners'. The GMC has published guidance on becoming a recognised Autonomous Practitioner and doctors are encouraged to develop evidence of their skills in leadership, management and research. These slides provide a clear rationale for an SAS Leadership Fellow programme to support SAS doctors in their medical careers.
Implementing a shared care model to prevent liver cancer and improve chronic ...Cancer Institute NSW
Hepatocellular cancer (HCC) is among the top 10 causes of cancer death in Australia, with ~80% of cases attributable to chronic viral hepatitis. Although 60-80% of HCCs are preventable by antiviral therapies, multiple barriers exist in the diagnostic and treatment continuum. Chronic hepatitis B (CHB) is the main cause for rising HCC rates in Western Sydney, where the greatest burden of disease is among people born in hepatitis B endemic countries.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
A national learning event took place in June 2014, to explore how best to present data from the Cancer Patient Experience Survey (CPES) in order to drive improvement.
Outcomes from the event will help to shape the future presentation of CPES data, so that it is more accessible and easier for professionals and the public to use and interpret.
The event was held by NHS Improving Quality's Experience of Care team, in partnership with Macmillan Cancer Support, and NHS England's Insight team, to bring together cancer managers, lead nurses and lead clinicians. They heard from speakers including patient Bonnie Green, Ben Page, chief executive of Ipsos Mori, and Sean Duffy, National Clinical Director for cancer. Delegates also undertook group activity looking at the barriers that exist in translating data into improvement, and tailoring data for the right audiences.
The event forms part of NHS Improving Quality's wider work with NHS England looking at how the NHS is using the CPES data to reduce variation in the cancer patient experience. CPES, part of the national survey programme commissioned by NHS England, generates data and insight into the experiences of cancer patients.
- See more at: http://www.nhsiq.nhs.uk/news-events/news/using-insight-data-to-improve-patient-experience.aspx#sthash.Yh1yiQ6y.dpuf
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
Acute hospitals end of life care best practiceNHSRobBenson
Delivering reliable best practice in an acute hospital setting for patients whose recovery is uncertain. Including details of the AMBER care bundle. Presentation from Anita Hayes and colleagues from England's National End of Life Care Programme as part of the Department of Health's QIPP end of life care workstream seminar series at Healthcare Innovation Expo 2011
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Naz Usmani
A very brief presentation about the clinical process improvements including practices, standards of care , guideline and pathway . I have reflected upon the basic differences between them . Hope it is useful
ISCaHN Treatment Dashboard: Providing clinician decision support with data ge...Cancer Institute NSW
Illawarra Shoalhaven Cancer and Haematology Network (ISCaHN) has been using an oncology information system (OIS) as a complete electronic record for over 4 years. There has been both considerable and valuable treatment data generated at the point of care. Are we able to rapidly assess the outcomes of our own treatment data, and use this outcome data to help inform the delivery of care to our patients?
Methods for Observational Comparative Effectiveness Research on Healthcare De...Marion Sills
Research Objective: The SAFTINet project was funded by the AHRQ to build a distributed network of existing clinical and claims data that would support comparative effectiveness research (CER), with a focus on underserved populations and healthcare delivery system (HDS) characteristics. Observational research methods are appropriate, but require detailed protocols with a priori hypotheses and analytic plans. SAFTINet research specifically concerns the effects of a discrete set of HDS features (those often included in Patient-Centered Medical Home (PCMH) models) on health outcomes for primary care patients with asthma, hypertension, and hypercholesterolemia. Our objective is to present a description of this study’s measurement challenges, and to specify a priori hypotheses, analytic strategies, and plans for addressing bias and confounding for our asthma cohorts.
Study Design: An observational, longitudinal cohort study of primary care patients with asthma, with both secondary use of existing clinical and claims data and primary data collection for HDS features and patient- reported outcomes.
Population Studied: Our sample consists of 59 primary care practices in 5 healthcare organizations in Colorado, Utah and Tennessee; all practices serve underserved populations. These practices care for about 275,000 patients per year, of whom an estimated 22,000 have a diagnosis of asthma.
Principal Findings: We will present the processes used to define and measure the HDS features, covariates and asthma outcomes, along with planned analysis. Challenges include valid measurement of a multi-faceted HDS “exposure” variable, the inability to identify exposure onset, and the non-dichotomous nature of HDS characteristics. To measure HDS characteristics, we created a practice-level survey assessing 9 PCMH domains, including care coordination, specialty care and mental health integration, and patient-centeredness, as well as asthma-specific HDS characteristics (e.g., the use of asthma registries). Asthma outcomes included (1) those available as a result of routine electronic documentation of clinical care and claims administration (utilization indicative of an exacerbation), and (2) patient reported outcomes tools (Asthma Control Test). We used directed acyclic graphs to identify potential confounders of the relationship between HDS characteristics and asthma control, as well as other potential biases. The analytic plan is based on linear mixed effects models. Perspectives of the CER team, the technology team and the community engagement group were considered in the operationalization of all variables.
Conclusions: The design of rigorous observational CER observational CER should recognize the need for an intense planning phase. In accordance with good practice guidance for observational studies, an important component of the planning phase is to disseminate and obtain feedback on the research design in advance of its conduct.
Building the bridge from discovery-to-delivery: A Community of Practice in Ca...Cancer Institute NSW
A research breakthrough is said to take approximately 17 years to translate into clinical practice. This time lag can have considerable implications for patients, their carers, health services, and public funds. To address this time lag, the Cancer Institute NSW and the Translational Cancer Research Centres (TCRCs) across the state developed a community of practice (CoP) to increase knowledge, skills, and capacity in implementation science.
Pathways to smoking care for cancer patients (P-SCIP): Stage 1Cancer Institute NSW
As survival from cancer has improved over time, the potential impact of cigarette smoking on cancer patients and survivors is of increasing relevance. In addition to increased risk of chronic disease such as cardiovascular and respiratory disease, continued smoking after a cancer diagnosis increases the risk of second primary cancer, cancer recurrence and is a cause of treatment complications. As well the profound adverse impact of continued smoking on health outcomes in cancer patients, continued smoking among people with cancer incurs significant cost to the health system.
Member experiences in an Australian Translational Cancer Research Centre and ...Cancer Institute NSW
The experience of membership of multidisciplinary collaborative cancer research networks is largely unreported. Sydney Catalyst Translational Cancer Research Centre (TCRC) is a multi-disciplinary and multi-institutional virtual consortium of researchers and clinicians from institutions in metropolitan Sydney and regional New South Wales. Following the Westfall model of translational research, we support multi-disciplinary collaborative cancer research focused on T1112 bench to bedside research and T2/3 translation of evidence into practice.
Paul Bristow, BKPA, and Karen Thomas, UKRR gave a presentation at BRS2017: Embedding patient reported experience into future QI - 1st National PREM Pilot Survey 2016
Specialist and Associate Specialist (SAS) doctors are highly experienced and highly skilled doctors working in the UK NHS. Now SAS doctors can register with their employer to be recognised as 'Autonomous Practitioners'. The GMC has published guidance on becoming a recognised Autonomous Practitioner and doctors are encouraged to develop evidence of their skills in leadership, management and research. These slides provide a clear rationale for an SAS Leadership Fellow programme to support SAS doctors in their medical careers.
Implementing a shared care model to prevent liver cancer and improve chronic ...Cancer Institute NSW
Hepatocellular cancer (HCC) is among the top 10 causes of cancer death in Australia, with ~80% of cases attributable to chronic viral hepatitis. Although 60-80% of HCCs are preventable by antiviral therapies, multiple barriers exist in the diagnostic and treatment continuum. Chronic hepatitis B (CHB) is the main cause for rising HCC rates in Western Sydney, where the greatest burden of disease is among people born in hepatitis B endemic countries.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
A national learning event took place in June 2014, to explore how best to present data from the Cancer Patient Experience Survey (CPES) in order to drive improvement.
Outcomes from the event will help to shape the future presentation of CPES data, so that it is more accessible and easier for professionals and the public to use and interpret.
The event was held by NHS Improving Quality's Experience of Care team, in partnership with Macmillan Cancer Support, and NHS England's Insight team, to bring together cancer managers, lead nurses and lead clinicians. They heard from speakers including patient Bonnie Green, Ben Page, chief executive of Ipsos Mori, and Sean Duffy, National Clinical Director for cancer. Delegates also undertook group activity looking at the barriers that exist in translating data into improvement, and tailoring data for the right audiences.
The event forms part of NHS Improving Quality's wider work with NHS England looking at how the NHS is using the CPES data to reduce variation in the cancer patient experience. CPES, part of the national survey programme commissioned by NHS England, generates data and insight into the experiences of cancer patients.
- See more at: http://www.nhsiq.nhs.uk/news-events/news/using-insight-data-to-improve-patient-experience.aspx#sthash.Yh1yiQ6y.dpuf
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
Acute hospitals end of life care best practiceNHSRobBenson
Delivering reliable best practice in an acute hospital setting for patients whose recovery is uncertain. Including details of the AMBER care bundle. Presentation from Anita Hayes and colleagues from England's National End of Life Care Programme as part of the Department of Health's QIPP end of life care workstream seminar series at Healthcare Innovation Expo 2011
BPS DCP SIGOPAC Good Practice Guidance in Demonstrating Quality and Outcomes ...Alex King
This report outlines a rigorous, multidimensional framework for evaluating quality and outcomes in psycho-oncology services, which can be flexibly adapted to local needs and priorities.
It aims to challenge psycho-oncology services to develop and standardise procedures that address the clinical and operational aspects of quality, while maintaining a firm focus on the experiential.
The proposed framework focuses on six key domains of service quality:
- Is this service safe?
- Is this service equitable, while also focused on those most in need?
- Is this service timely and responsive?
- Is this service respectful, collaborative and patient-centred?
- Is this service offering effective interventions?
- Is this service contributing to efficient multidisciplinary care?
To address these domains, psycho-oncology services need to draw on multiple, convergent sources of data, including key performance indicators, activity levels, patient self-report measures, feedback from professional colleagues, etc.
American Public Health Association- Annual Meeting 2014 Presentation scherala
Title: Using Quantitative Data to focus Medical Home Facilitation Interventions in the Massachusetts Patient Centered Medical Home Initiative (MA PCMHI)
Research on consequences of cancer and its treatment on quality of life, symp...Nata Chalanskaya
Susanne Oksbjerg Dalton, Group Head, consultant, Danish Cancer Society Research Center, Danish Cancer Society, presentation at the Second International Scientific and Practical Conference «Improving the quality of life of cancer patients through the development of cooperation between state, commercial and non-profit organizations». 2018-01-23, Minsk. Belarus.
NICE Master Class final presentation 25 11 14 (including workshops)NEQOS
Collaborating for Better Care Partnership Master Class with NICE: 'Putting Evidence into Practice' - complete ppt slide pack including the workshop ppts and web links.
A joint presentation on Real People, Real Data at the 2016 International Forum on Quality and Safety in Healthcare in Gothenburg, Sweden. Presented by Leanne Wells of the Consumers Health Forum of Australia; Sam Vaillancourt of St. Michael’s Hospital, Toronto, Canada, and; Dr Paresh Dawda of the Australian National University.
Presentations from the patient safety conference held at Teesside University on 1 and 2 September 2014 - Students at the forefront of continuing and improving our culture of safe care
Stopping over-medication of People with Learning Disabilities
(STOMPLD) 2016.
Reducing Inappropriate Psychotropic Drugs in People with a Learning Disability in General Practice and Hospitals in 2016.
Presentation slides Frailty: building understanding, empathy and the skills t...NHS Improving Quality
Frailty: building understanding, empathy and the skills to support self-care
Guest speaker:Dr Dawn Moody, Director - Fusion48
An opportunity to learn about some innovative approaches to making the health and care workforce 'Fit for Frailty'* (*British Geriatrics Society 2015).
Learning outcomes:
To explore the Frailty Fulcrum as a tool for holistic assessment and management of frailty
To hear how Virtual Reality is being used to build empathy for older people living with frailty
To learn about the impact of a county-wide, multi-agency, multi-professional training an toolkit for care professionals working with older people
Resources:www.fusion48.net
Self-management in the community and on the Internet - Presentation 22nd Marc...NHS Improving Quality
LTC Lunch & Learn webinar:- 22nd March 2016
Presenter:- Pete Moore, Educator, Author & Pain Toolkit Trainer
As pain is the most daily health problem reported to a GP-
Developing a national pain strategy- reviews from around the world
Electronic Palliative Care Coordination Systems (EPaCCS): Improving Patient C...NHS Improving Quality
Speaker slides from the national conference, 'Electronic Palliative Care Coordination Systems (EPaCCS): Improving Patient Care at End of Life', 17 March 2016
Fire service as an asset: providing telecare support in the community Webinar...NHS Improving Quality
Guest speaker: Steve Vincent - West Midlands Fire Service & Simon Brake from Coventry Council
Hosted by: Bev Matthews, Long Term Conditions Programme Lead, NHS England
Learning Outcomes:-
To better understand the role that the Fire and Rescue service can provide as a community asset to support health needs Enhancing the quality of life for people by supporting them to stay in their own home, even in a crisis
An overview of the work carried out by NHS England and NHS Improving Quality's Long Term Conditions Sustainable Improvement Team. It puts the case for why person-centred care has to be at the heart of healthcare.
Commissioning Integrated models of care
Kent LTC Year of Care Commissioning Early Implementer Site
Alison Davis, Integration Programme Health and Social Care, Working on behalf of Kent County Council and South Kent Coast and Thanet CCG's
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
5. The journey so far…
EVENT
Improving Care: More Method, Less Uncertainty
The first in a series of measurement master-classes for senior clinicians
Friday 6th
September
WEBINAR
Thursday
10th Oct
Dr Bob Lloyd, Institute for Healthcare Improvement US, Professor Moira Livingston, NHS
Improving Quality, Professor Sir Bruce Keogh, NHS England, Julian Hartley, NHS
Improving Quality, Dr Maxine Power, Salford Royal NHS Foundation Trust
Different national approaches - how to use national data to drive improvement at all
levels
Dr Veena Raleigh, Kings Fund, Göran Henriks, Jönköping County Council, Sweden, Prof
Jonathon Gray, Dr Mataroria Lyndon, Counties Manukau Health, New Zealand
WEBINAR
Thursday
17th Oct
Different national approaches – mortality, exploring how to use complex indicators to
drive improvement
WEBINAR
Different national approaches - improvement and transparency
Dr Bob Lloyd, Institute for Healthcare Improvement US, Dr Anna Trinks, Jönköping
19 Delegates County Council, Sweden
Wednesday Dr Carol Peden, Royal United Hospital Bath, Alide Chase, Diane Waite, Kaiser
23rd Oct
Permanente, US
6. Shape of the day
Time
0930-0945
0945-1000
1000-1100
1115-1130
1130-1230
1230-1310
1310-1430
1430-1550
1550-1600
Topic
Lead
Welcome, introductions and overview of the
day
Professor Moira Livingston
Clinical Director of Improvement Capability NHS
Improving Quality
View from the top
Professor Sir Bruce Keogh
National Medical Director, NHS England
The strategic measurement for improvement
journey
• Choosing the right measures
Mike Davidge with
Dr Bob Lloyd (15 min video)
Dr Maxine Power
Dr Veena Raleigh
Break
The strategic measurement for improvement
journey
• Collecting good data
• Making sense of data
Lunch
Knowledge Exchange: Making it happen
• Details on your desks
Steering the measurement journey: what
next?
Summary and Closing
Mike Davidge with
Dr Maxine Power
Dr Veena Raleigh
Mark Outhwaite
Mark Outhwaite
Professor Sir Bruce Keogh
7. Purpose of the impact summit
The key aims:
• Reflect and review learning and implications from the master-class so far
• Build depth of knowledge
• Discuss and identify how to make improvements in our measurement systems– based on
better / more informed decision making
• Promote understanding of the difference between measurement for improvement and for
other purposes
• Share and embed practical techniques for choosing measures, applying measures and
interpreting measures
We will do this by:
• Case studies of real world examples, with opportunity to discuss and question
• Providing interactive sessions to work through some personal measurement challenges, to
identify some actions and next steps
• Create the opportunity to identify further support needed to take for forward a
measurement for improvement system, culture and practices
Note: this course will be eligible for CPD points, information to be circulated after the event
8. Speakers for this morning
Professor Sir Bruce Keogh
National Medical Director, NHS England
Mike Davidge
Director (Measurement), NHS Elect
Veena S Raleigh PhD
Senior Fellow, The King’s Fund
Maxine Power PhD, MPH
Director of Innovation and Improvement Science, Salford Royal
NHS Foundation Trust and Managing Director of Haelo
9. Knowledge Exchange Speakers
• Mel Varvel, Improvement Manager, NHS Improving Quality
• Preventing People from Dying Prematurely: GRASPing the Measurement
Nettle
• Dr Frances Healey, RGN, RMN, PhD, Senior Head of Patient Safety Intelligence, NHS
England & Matthew Foggarty, Patient Safety, NHS England
• The genie is out of the bottle: when Measurement for Improvement is used
for other purposes
• Clare Howard, MRPharmS, Deputy Chief Pharmaceutical Officer NHS England
• Developing metrics for safer medication practice
• Dr Carol Peden, Quality Improvement Fellow-Health Foundation and Consultant in
Anaesthesia and Critical Care Medicine, Royal United Hospital Bath
• Mortality Reviews
• Martin McShane, Director (Domain 2) Improving the quality of life for people with
Long Term Conditions, NHS England & Professor Alistair Burns, National Clinical
Director for Dementia, NHS England and The University of Manchester
• Dementia
12. Using Poll Everywhere
Live feedback and polling
Either
Text: mfimp to 07624806527
to link your phone to the session
Then all you do is send poll responses to that number as a normal
SMS/text
Will not work if you withhold your number
Or
Point your smartphone/tablet browser at
www.pollev.com/mfimp
To participate in the polls
Wifi: MMCNHSIQ – no password
No premium costs – just contained within your normal contract
rates
15. A word from our teacher
• Bob Lloyd reminds us
briefly what he covered
on 6th September
• We will be revisiting
some of these points
this morning with
practical exercises
16. Be clear why you are measuring and the messiness of life
CHOOSING THE RIGHT MEASURES
18. Precursors of measurement: clarity about...
Who (audience): providers, commissioners, patients etc
Why (aim):
- quality improvement, judgement, research
What (content):
- dimension of quality, efficiency
- population, service/sector, pathway
- unit of measurement
How (process):
- definition, data sources
- statistical methods
- interpretation
19. Audience for measurement (1)
parliament / government
the NHS:
- commissioners
- managers
- professional staff
patients, families, carers
the public
regulators, auditors
researchers
the media
The appropriate content and presentation formats of indicators
for these audiences differ
20. Audience for measurement (2)
For example:
clinicians need disaggregated, risk-adjusted information at small unit
level, benchmarked against peers, and showing trends over time
commissioners want information on outcomes, and quality linked to
cost-effectiveness
patients, public want information that is simply constructed, clearly
presented, and easy to interpret ie good vs bad
21. Aim of measurement
•
Judgement:
- performance assessment/management
- incentivising quality improvement (P4P eg QOF, CQUIN, quality premiums)
- supporting patient choice
- public accountability
assumes unambiguous evidence of performance,
designed for EXTERNAL accountability
or
•
Quality improvement:
- internal use
- benchmarking against peers for feedback and learning
assumes indicators are 'tin openers' for INTERNAL use, designed to
prompt further investigation and appropriate action
22. Indicators for judgement
Indicators for improvement
unambiguous interpretation
variable interpretation possible
unambiguous attribution
ambiguity tolerable
definitive marker of quality
screening tool
good data quality
‘good enough’ data quality
good risk-adjustment
partial risk-adjustment tolerable
statistical reliability
preferred but not essential
cross-sectional
time trends (SPCs, run charts etc)
punishment/reward
learning, change in practice
external control
internal control
data for public use
data for internal use
stand-alone
allowance for context
risk of unintended consequences
low risk
23. Content of measurement (1)
dimension of quality:
effectiveness, patient experience, safety ………..
timely, access, equity, VfM, care coordination and integration
population group, condition, service
structure, process and outcome indicators: S + P = O
unit of measurement eg commissioner and/or provider
24. Content of measurement (2)
Indicators for commissioners (CCGs, LAs):
- population based
Indicators for providers:
- Primary care
- Community care
- Out-of-hours care
- Hospital care (emergency and planned)
- Tertiary and specialist care
- Mental health care
- Palliative care
- Social care (residential & home care)
Indicators by
population group,
condition
25. Example: cancer
NHSOF / COIS domain 1 indicators:
cancer mortality < 75
cancer survival
reducing cancer mortality depends on:
reducing cancer incidence AND
improving cancer survival
these outcomes require improvement in the underlying drivers eg:
cancer incidence: preventive measures eg smoking cessation services
(process measure)
cancer survival: screening, timely referral, treatment rates (process measures),
staff capacity/skills and surgical volumes (structure measures)
26. Cancer
(example indicators)
Inequalities
PRIMARY OUTCOME MEASURES
Cancer mortality O
Cancer incidence O
Risk factors and prevention
Rates of:
- incidence O
- smoking prevalence, diet etc IO
- population awareness P
- no of smoking cessation clinics S
- smoking quitters O
Key
S=structure measure
P=process measures
IO=intermediate outcome measure
O=outcome measures
Cancer survival O
Diagnosis, treatment, end-of-life care
Rates of:
- screening P
- referrals, diagnostic tests, time to results P
- detection rates O
- stage at diagnosis O
- access, waiting times P
- cancers detected at emergency presentation P
- surgical volumes S
- treatment (surgery, radiotherapy) rates P
- information for patients P
- length of stay, readmission, mortality rates O
- one-year survival: proxy for late diagnosis O
- management by a multidisciplinary team P
- staff skills, training S
- adherence to guidelines P
- access to end-of-life care P
- patient experience and wellbeing O
- cancer deaths by place of death O
- participation in national clinical audits S
27. Aims exercise
If you were in a lift with the rest of your table group
could you clearly and briefly describe your aim in a
sentence – i.e. the time it takes to travel from one
floor to the next?
Write your aim
statement down
Share with your
table
30
30. What is a Driver Diagram?
•
•
•
•
•
Reinforces the aim statement as the goal
Clarifies the big picture
Identifies primary system components
Identifies projects which will influence
Aids in development of measurement
Most importantly: Helps to articulate the overall aim
and avoid missing important system components
33
31. What are driver diagrams used for?
•
•
•
•
Personal improvement projects
Clarification in complex tasks
Project / Programme Management
Strategy, design and execution
32.
33. Primary Drivers
•
•
•
•
•
•
Push conceptual thinking
Avoid focus on one area alone
Usually categorical
Abstract
Removal reduces likelihood of success
Projects wrap into them
35. My driver diagram for weight loss
Healthy Eating
Lose
2 stone
Measurement &
feedback
by March
2014
Prevent avoidable
complications
(Lifestyle)
Exercise
•Regular shopping
•More fresh fruit
•3 meals per day
•No food after 6pm
•2 litres of water per day
•Weekly weight
•Measure Inches
•Pictures on the fridge
•Regular support
•Weight record chart updated showing trend
•Plan for eating out / weekends
•Beer & wine – develop a plan
•Know your weaknesses
•Habits and patterns
•Avoid bad influencers
•Encourage contact with supportive people
•Daily exercise for a minimum of 20 mins
•Measure progress
•Identify barriers
•Build distractions to help
•Add something nice – sauna / jacuzzi
•Search for an exercise that suits
36. Agree Operational
Definitions
Develop &
test a
measurement
instrument for
harm free care
from pressure
ulcers, falls,
catheters and
VTE by
September
2011
• Evidence review
• Expert debate / in
• Grey areas agreed
• Practical use
Develop Technical Capability
• Design characteri
• Local, regional, na
• Universal platform
• Guidelines for use
Determine how the
instrument is used
• Who collects & w
• From where?
• What happens aft
• How are data use
Determine the level of user
• Local users - feedb
• Data leads - feedb
41. Cancer
(example indicators)
Inequalities
PRIMARY OUTCOME MEASURES
Cancer mortality O
Cancer incidence O
Risk factors and prevention
Rates of:
- incidence O
- smoking prevalence, diet etc IO
- population awareness P
- no of smoking cessation clinics S
- smoking quitters O
Key
S=structure measure
P=process measures
IO=intermediate outcome measure
O=outcome measures
Cancer survival O
Diagnosis, treatment, end-of-life care
Rates of:
- screening P
- referrals, diagnostic tests, time to results P
- detection rates O
- stage at diagnosis O
- access, waiting times P
- cancers detected at emergency presentation P
- surgical volumes S
- treatment (surgery, radiotherapy) rates P
- information for patients P
- length of stay, readmission, mortality rates O
- one-year survival: proxy for late diagnosis O
- management by a multidisciplinary team P
- staff skills, training S
- adherence to guidelines P
- access to end-of-life care P
- patient experience and wellbeing O
- cancer deaths by place of death O
- participation in national clinical audits S
42. PRIMARY PREVENTION
REDUCE
MORTALITY
FROM CANCER
IN ENGLAND
BY XX% BY
MARCH 2016
•
•
•
•
Lifestyle
Genetics
Campaigns
Social determinants
SECONDARY PREVENTION
•
•
•
•
•
Screening
Primary care
Access to L2/3 service
Lifestyle change
Medicines optimisation
SERVICE OPTIMISATION
•
•
•
•
Value driven
Quality greater than cost
Equity in access
Excellent experience
END OF LIFE AND SOCIAL CARE
•
•
•
•
•
Cross sector working
Hospice & faith
Seven day HSC service
Equipment
Pain management
44. Limitations of driver diagrams
• Not a perfect science
• Two dimensional & simplistic
• Working schematic – requires amendment
• Interplay between drivers
• Contribution of each driver is not equal
50. Define measures
An operational definition is a description, in quantifiable
terms, of what to measure and the steps to follow to
measure it consistently
51. Example definition
Measure name:
DNA rate for clinic A
Why is it important?
(Provides justification and any links to organisation strategy)
We need to ensure that the clinic is not disrupted by having unexpected gaps in the
clinic schedule. The policy for this clinic is to offer another appointment which means
that other patients may be disadvantaged if we have too many patients being
rescheduled.
Who owns this measure?
(Person responsible for making it happen)
Measure definition
The outpatient clinic manager
What is the definition?
(Spell it out very clearly in words)
The percentage of patients booked to attend clinic A who did not attend for
their appointment and no warning was received at the clinic before it started.
What data items do you need?
The number of patients booked to attend clinic (B) and the number of patients
who failed to attend without warning (F)
What is the calculation?
100 x DNA patients (F) / Booked patients (B)
Which patient groups are to be covered? Do you need to stratify? (For example, are there
differences by shift, time of day, day of week, severity etc)
All patients booked into clinic
52. Collecting data
• What – All patients, a
portion or a sample?
• Who – collects the data?
• When – is it collected
– real time or retrospective?
• Where – is it collected?
• How – is it obtained
– Computer system or audit?
You need a plan which you test using PDSA cycles
53. Checklist exercise
• Complete page one and
collect on page two of the
measures checklist provided for a measure that you are
using or are planning to use
• Share with your colleagues
You have 15 minutes
57. Variation exercise
• Using the materials provided make
the best paper aeroplane you can
• Put your initials on it
You have 15 minutes
When instructed - throw your planes!
58. Fishbone diagram
Equipment
People
Procedures
Skills / ideas
Some tables
had scissors,
rulers to help
Throwing styles
Problem
No clear
instructions
provided
Causes
Air /Wind
Environment
Types of
paper e.g.
card, tracing
paper,
Materials
Aeroplanes fly
different
distances
59. Classifying variation
Common
Cause
Stable in time and
therefore relatively
predictable
The paper used
Persons technique
Design of the plane
Mike’s plane
Special
Cause
Irregular in time
and therefore
unpredictable
Water spill
60. Why classify variation?
“There are different improvement strategies depending
of which type of variation is present (common cause or
special cause), so it is important for a team to know the
difference.”
Michael George
Chairman and CEO of George Group
Consulting
64. The Knowledge Exchange Carousel
• After lunch you will be directed to move direct to a Knowledge
Exchange Carousel ‘Pod’ with the same number as your table
number
• You will rotate through 3 ‘Pods’ at 25 minute intervals
• In each Pod you will discuss a case study presented by a speaker
• After the third Knowledge Exchange session you will remain in
the Pod for the next task
65. Knowledge Exchange Speakers
• Mel Varvel, Improvement Manager, NHS Improving Quality
• Preventing People from Dying Prematurely: GRASPing the Measurement
Nettle
• Dr Frances Healey, RGN, RMN, PhD, Senior Head of Patient Safety Intelligence, NHS
England & Matthew Foggarty, Patient Safety, NHS England
• The genie is out of the bottle: when Measurement for Improvement is used
for other purposes
• Clare Howard, MRPharmS, Deputy Chief Pharmaceutical Officer NHS England
• Developing metrics for safer medication practice
• Dr Carol Peden, Quality Improvement Fellow-Health Foundation and Consultant in
Anaesthesia and Critical Care Medicine, Royal United Hospital Bath
• Mortality Reviews
• Martin McShane, Director (Domain 2) Improving the quality of life for people with
Long Term Conditions, NHS England & Professor Alistair Burns, National Clinical
Director for Dementia, NHS England and The University of Manchester
• Dementia
66. Sharing your learning
• At the end of the Knowledge
Exchange you will remain in
your last Pod
• Using the A0 poster template
rapidly brainstorm the Barriers
and Drivers in the current
environment for each step in
the measurement process
• Identify your top 2 Barriers
and top 2 Drivers (dot vote if
necessary)
• Transfer them to your Action
Planner Driver Diagram
67. Action Planning
• Identify the actions you
could take collectively as a
senior leadership cadre to
address the barrier or
driver
Or
• The support you need as a
senior leadership cadre to
address the barrier or
driver
68. Feedback
• One barrier or driver and the associated actions
• One headline – if a journalist had been in the Pod with you what
would be the headline they would have written
75. The Improving Care: More
Method, Less Uncertainty,
Impact summit
Further details about the webinar series :
www.nhsiq.nhs.uk
Editor's Notes
Poll Title: Tell us where you think you are on the journey through measurement for improvement:
http://www.polleverywhere.com/multiple_choice_polls/IriLN7as9lA4v2o
Poll Title: What are the 3 reasons for measurement?
http://www.polleverywhere.com/multiple_choice_polls/Bfm432nVHsWmPLa
Maxine will describe driver diagrams
Poll Title: How confident are you now in using driver diagrams to address the messiness of life?
http://www.polleverywhere.com/multiple_choice_polls/0tK65pO461iwq7O
Poll Title: A good measure
http://www.polleverywhere.com/multiple_choice_polls/h66EoN6rffAJXjI
Operational definitionSimple exercise to bring home the point – how many wearing red?
This is a simple example using DNA as a measure. It is sufficiently generic to appeal to a wide range of projects and delegatesGo through each section but focus on the calculation. Explain that the definition needs to be comprehensive enough to avoid ambiguity
Operational definitionSimple exercise to bring home the point – how many wearing red?
Poll Title: Thinking back to the Checklist exercise, how much has that changed your thinking about the definition and collection of your chosen measure?
http://www.polleverywhere.com/multiple_choice_polls/kwxwrAJxIwvxidq
Poll Title: What is an operational definition
http://www.polleverywhere.com/multiple_choice_polls/OkbekndyzWBtIbl
Poll Title: Run and control charts are used to track progress over time because they allow us to identify common and special cause variation. How are you using them in your work:
http://www.polleverywhere.com/multiple_choice_polls/z7Ax0OdBmlcYjXd
Poll Title: Why is it important to identify which type of variation we have in our data?
http://www.polleverywhere.com/multiple_choice_polls/FMXovzDO3BYQKDB
Poll Title: Share thoughts and reflections during the afternoon session
http://www.polleverywhere.com/free_text_polls/7yl1qrB7kxLYqsB